Bakhshi S - Search Results

1

Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician's perspective.

Pushpam D, Bakhshi S. Pushpam D, et al. Among authors: bakhshi s. Daru. 2020 Jun;28(1):371-385. doi: 10.1007/s40199-019-00321-z. Epub 2020 Jan 3. Daru. 2020. PMID: 31900888 Free PMC article. Review.

2

Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country.

Medhi K, Raina V, Kumar L, Sharma A, Bakhshi S, Gupta R, Kumar R. Medhi K, et al. Among authors: bakhshi s. Leuk Lymphoma. 2010 Oct;51(10):1850-4. doi: 10.3109/10428194.2010.507416. Leuk Lymphoma. 2010. PMID: 20849386 Clinical Trial.

3

Childhood chronic myeloid leukemia with monocytosis.

Gupta N, Gupta R, Sharawat SK, Bakhshi S. Gupta N, et al. Among authors: bakhshi s. Indian J Pediatr. 2010 Oct;77(10):1143-5. doi: 10.1007/s12098-010-0200-4. Epub 2010 Sep 30. Indian J Pediatr. 2010. PMID: 20882436

4

Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemia.

Samaiya M, Bakhshi S, Shukla AA, Kumar L, Chauhan SS. Samaiya M, et al. Among authors: bakhshi s. J Cell Mol Med. 2011 Oct;15(10):2189-99. doi: 10.1111/j.1582-4934.2010.01203.x. J Cell Mol Med. 2011. PMID: 21496199 Free PMC article.

5

Imatinib-induced avascular necrosis of femur in childhood chronic myeloid leukemia.

Nataraj V, Kandasamy D, Bakhshi S. Nataraj V, et al. Among authors: bakhshi s. Pediatr Hematol Oncol. 2014 Apr;31(3):268-70. doi: 10.3109/08880018.2013.862588. Epub 2014 Jan 2. Pediatr Hematol Oncol. 2014. PMID: 24383853 No abstract available.

6

Indicators of malnutrition in children with cancer: A study of 690 patients from a tertiary care cancer center.

Srivastava R, Pushpam D, Dhawan D, Bakhshi S. Srivastava R, et al. Among authors: bakhshi s. Indian J Cancer. 2015 Apr-Jun;52(2):199-201. doi: 10.4103/0019-509X.175825. Indian J Cancer. 2015. PMID: 26853403 Free article.

7

miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia.

Ramachandran SS, Muiwo P, Ahmad HM, Pandey RM, Singh S, Bakhshi S, Kumar L, Bhattacharya A, Gupta YK. Ramachandran SS, et al. Among authors: bakhshi s. Leuk Lymphoma. 2017 Aug;58(8):1981-1984. doi: 10.1080/10428194.2016.1272681. Epub 2017 Jan 16. Leuk Lymphoma. 2017. PMID: 28093001 No abstract available.

8

Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.

Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A, Shastri SS, Biswas NR, Gupta YK. Harivenkatesh N, et al. Among authors: bakhshi s. Pharmacol Res. 2017 Jun;120:138-145. doi: 10.1016/j.phrs.2017.03.011. Epub 2017 Mar 19. Pharmacol Res. 2017. PMID: 28330783

9

Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?

Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A, Shastri SS, Gupta YK. Harivenkatesh N, et al. Among authors: bakhshi s. Leuk Lymphoma. 2017 Sep;58(9):1-9. doi: 10.1080/10428194.2017.1287359. Epub 2017 Apr 3. Leuk Lymphoma. 2017. PMID: 28367681

10

Impact of Pediatric Malignancies on Parent's Quality of Life.

Pushpam D, Bakhshi S. Pushpam D, et al. Among authors: bakhshi s. Indian J Pediatr. 2018 Sep;85(9):713-714. doi: 10.1007/s12098-018-2735-8. Epub 2018 Jun 28. Indian J Pediatr. 2018. PMID: 29951781 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

731 results

Search Page

Filters